Article
Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
Stem cells and development - 15 Oct 2013
Dick Emily, Kalra Spandan, Anderson David, George Vinoj, Ritso Morten, Laval Steven H, Barresi Rita, Aartsma-Rus Annemieke, Lochmüller Hanns, Denning Chris
Abstract excerpt
With an incidence of ∼1:3,500 to 5,000 in male children, Duchenne muscular dystrophy (DMD) is an X-linked disorder in which progressive muscle degeneration occurs and affected boys usually die in their twenties or thirties. Cardiac involvement occurs in 90% of patients and heart failure accounts for up to 40% of deaths. To enable new therapeutics such as gene therapy and exon skipping to be tested in human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
